Simulations Plus, Inc. - Common Stock (SLP)

Simulations Plus Inc is a leading provider of advanced software and consulting services for the pharmaceutical and biotechnology industries

The company specializes in modeling and simulations that aid in drug discovery and development, including pharmacokinetics and pharmacodynamics. By offering powerful tools and platforms, Simulations Plus enables researchers to predict and analyze drug behavior and interactions, ultimately enhancing the efficiency and success rate of developing new therapeutics. Their innovative solutions support various stages of the drug development process, helping clients streamline their research efforts, reduce costs, and bring new medications to market more effectively.